Results 71 to 80 of about 7,548 (263)

Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians [PDF]

, 2018
Type 1 diabetes mellitus (T1DM) is a chronic autoimmune condition that requires life-long administration of insulin. Optimal management of T1DM entails a good knowledge and understanding of this condition both by the physician and the patient.
American Diabetes Association, Bailey, Banting, Battelino, Beato-Víbora, Beck, Bergenstal, Bergenstal, Bolinder, Bolli, Boyne, Brown, Brunelle, Campbell, Choudhary, Chow, Clarke, Cox, Cox, Cranston, Cryer, DAFNE Study Group, Dandona, Danne, Davidson, Davis, de Zoysa, Diabetes Control and Complications Trial Research Group, Donnelly, Fanelli, Fokkert, Garg, Goeddel, Gogitidze Joy, Gold, Grunberger, Harris, Heise, Heller, Heller, Heller, Hepburn, Hopkins, Hutton, International Diabetes Federation, International Hypoglycaemia Study Group, Iqbal, Joy, Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Kinsley, Korzon-Burakowska, Lane, Lind, Lindholm, Little, Livingstone, Lund, Ly, Marques, Miller, Muhlhauser, Muhlhauser, Neal, Nordin, Novodvorsky, Novodvorsky, Pedersen-Bjergaard, Peters, Petrie, Petrie, Pickup, Pickup, Polonsky, Raccah, Ratner, Razavi Nematollahi, Rizza, Robinson, Rodbard, Rogers, Russell-Jones, Samann, Solini, Starostina, Tanenberg, Tattersall, Trevitt, Walford, Workgroup on Hypoglycemia, Wright, Wysham, Zaykov, Zhang, Zinman   +93 more
core   +2 more sources

Managing feline diabetes: current perspectives [PDF]

, 2018
Diabetes mellitus is a common endocrine disease in cats. While type 2 diabetes is the most common form seen in cats, other underlying causes may contribute to insulin resistance.
Gottlieb, Susan, Rand, Jacquie
core   +1 more source

Strategies to Improve the Lipophilicity of Hydrophilic Macromolecular Drugs

Advanced Healthcare Materials, Volume 15, Issue 5, 2 February 2026.
Hydrophilic macromolecular drugs can be successfully lipidized by covalent attachment of lipids, by hydrophobic ion pairing with negatively or positively charged surfactants, and by dry or wet reverse micelle formation. Lipophilicity enhancement of hydrophilic macromolecules has several benefits including stability and bioavailability improvement ...
Sera Lindner, Stefan Keim, Soheil Haddadzadegan, Odile Fernandez Romero, Katrin Zöller, Gabriel Stern, Ilaria Cesi, Krum Kafedjiiski, Andreas Bernkop‐Schnürch   +8 more
wiley   +1 more source

Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study

International Journal of Endocrinology, 2015
The aim of this study was to investigate the efficacy of insulin degludec used for basal-bolus insulin regimen after switching from twice-daily basal insulin in Japanese patients with type 1 diabetes mellitus.
Yuka Tosaka, Akio Kanazawa, Fuki Ikeda, Mayu Iida, Junko Sato, Kazuhisa Matsumoto, Toyoyoshi Uchida, Yoshifumi Tamura, Takeshi Ogihara, Tomoya Mita, Tomoaki Shimizu, Hiromasa Goto, Chie Ohmura, Yoshio Fujitani, Hirotaka Watada   +14 more
doaj   +1 more source

Six‐Year Trends in Real‐World Data Use for Post‐Marketing Surveillance of New Medical Products in Japan

Clinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT The Ministerial Ordinance on Good Post‐Marketing Study Practice for Drugs was amended by the Ministry of Health, Labour and Welfare (MHLW) in 2018 to clearly define post‐marketing database studies (DBS) as a measure of pharmacovigilance activities for approved medical products in Japan.
Suguru Okami, Kako Shimotsumagari, Yasunari Sadatsuki   +2 more
wiley   +1 more source

Review for "Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial"

, 2021
Junichiro Irie
openalex   +2 more sources

Safety of Insulin Degludec/Insulin Aspart in Patients with Diabetes Mellitus over a Period of 1 Year during Routine Clinical Care in India: SMART (Study of Management of Diabetes with Ryzodeg™ Treatment) [PDF]

, 2021
Jothydev Kesavadev, Ambanna Gowda, Harish Kumar, Sadasiva Rao Yalamanchi, Sailesh Lodha, Kiran Pal Singh, Debasis Basu, Arthur Asirvatham, Navneet Shah, Muzammil Khan A Pathan, Manjunatha Revanna, Jagat J. Mukherjee   +11 more
openalex   +1 more source

When intensive insulin therapy (MDi) fails in patients with type 2 diabetes: Switching to GLP-1 receptor agonist versus insulin pump [PDF]

, 2016
Treatment with insulin, alone or with oral or injectable hypoglycemic agents, is becoming increasingly common in patients with type 2 diabetes. However, approximately 40% of patients fail to reach their glycemic targets with the initially prescribed ...
Castaneda, Javier, Cohen, Ohad, FILETTI, SEBASTIANO, Glandt, Mariela, MARANGHI, MARIANNA   +4 more
core   +2 more sources

Early subcutaneous basal insulin with intravenous insulin infusion for diabetic ketoacidosis management: A systematic review and meta‐analysis of randomised controlled trials

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1036-1048, February 2026.
Abstract Aims To evaluate the effectiveness and safety of early initiation of subcutaneous (SC) basal insulin in combination with intravenous insulin infusion (IVII), compared with IVII alone, for the management of diabetic ketoacidosis (DKA). Materials and Methods A systematic search of PubMed, Embase, Scopus, and the Cochrane Library was conducted to
Kitti Thammakosol, Patteera Vongtangton, Pawin Numthavaj, Arunrat Auttara‐atthakorn, Chutintorn Sriphrapradang   +4 more
wiley   +1 more source

Improved Cardiovascular and Cardiometabolic Risk in Patients With Type 1 Diabetes and Autoimmune Polyglandular Syndrome Switched From Glargine to Degludec Due to Hypoglycaemic Variability

Frontiers in Endocrinology, 2018
Background: Cardiovascular disease is a frequent complication of type 1 diabetes (T1D). We evaluated the effectiveness of switching from glargine to degludec in reducing the cardiovascular risk factors, the Framingham risk score (FRS) and visceral ...
Valentina Guarnotta, Giulia Di Bella, Giuseppe Pillitteri, Alessandro Ciresi, Carla Giordano   +4 more
doaj   +1 more source